Domov › Mikrocitni rak pljuč › New York › New York City
Klinične študije za Mikrocitni rak pljuč v New York City, NY
22 študij za Mikrocitni rak pljuč išče udeležence na lokacijah v New York City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, New York
A Study of Armored CAR T Cells in People With Cancer
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Vključevanje udeležencevFaza 3
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering, New York
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Vključevanje udeležencevFaza 1
- NYU Langone Health, New York
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
Vključevanje udeležencevFaza 1
- New York University Cancer Institute, New York
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Vključevanje udeležencevFaza 1/2
- Columbia University Medical Center - Herbert Irving Pavilion, New York
A Study of LY4175408 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab
Vključevanje udeležencev
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Lung Cancer Biomarkers and Screening
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- NYU Cancer Institute at New York University Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Vključevanje udeležencevFaza 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Research Site 107, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Vključevanje udeležencevOpazovalna študija
- Icahn School of Medicine at Mount Sinai, New York
Študije za Mikrocitni rak pljuč v drugih mestih
- Houston, TX26 študij
- Arlington, VA23 študij
- Boston, MA21 študij
- Nashville, TN20 študij
- Los Angeles, CA20 študij
- Orlando, FL15 študij
- Dallas, TX13 študij
- Cleveland, OH13 študij
- Chicago, IL13 študij
- St. Louis, MO13 študij
- Detroit, MI12 študij
- Washington, DC12 študij
Druge študije v New York City
- Rak dojke136 študij
- Nemalicelični pljučni rak121 študij
- Rak (vse vrste)109 študij
- Rak prostate103 študij
- Metastatski rak93 študij
- Kolorektalni rak78 študij
- Rak jajčnikov69 študij
- Rak pljuč60 študij
- Množni mielom60 študij
- Rak trebušne slinavke60 študij
- Rak endometrija52 študij
- Akutna mieločna levkemija51 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.